Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
JJ Grob, N Aaronson, G Fierlbeck, W Tilgen… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE:: To compare, in 305 patients with advanced metastatic melanoma,
temozolomide and dacarbazine (DTIC) in terms of overall survival, progression-free survival …
temozolomide and dacarbazine (DTIC) in terms of overall survival, progression-free survival …
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
MR Middleton, JJ Grob, N Aaronson… - Journal of Clinical …, 2000 - cir.nii.ac.jp
抄録< jats: p> PURPOSE:: To compare, in 305 patients with advanced metastatic melanoma,
temozolomide and dacarbazine (DTIC) in terms of overall survival, progression-free survival …
temozolomide and dacarbazine (DTIC) in terms of overall survival, progression-free survival …
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
MR Middleton, JJ Grob, N Aaronson, G Fierlbeck… - 2000 - christie.openrepository.com
PURPOSE: To compare, in 305 patients with advanced metastatic melanoma, temozolomide
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
MR Middleton, JJ Grob, N Aaronson… - Journal of Clinical …, 2000 - europepmc.org
Purpose To compare, in 305 patients with advanced metastatic melanoma, temozolomide
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
[引用][C] Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
MR MIDDLETON, JJ GROB, B DRENO… - Journal of clinical …, 2000 - pascal-francis.inist.fr
Randomized phase III study of temozolomide versus dacarbazine in the treatment of
patients with advanced metastatic malignant melanoma CNRS Inist Pascal-Francis CNRS …
patients with advanced metastatic malignant melanoma CNRS Inist Pascal-Francis CNRS …
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
MR Middleton, JJ Grob, N Aaronson… - Journal of clinical …, 2000 - pubmed.ncbi.nlm.nih.gov
Purpose To compare, in 305 patients with advanced metastatic melanoma, temozolomide
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS) …
[引用][C] Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
M MR - J Clin Oncol, 2000 - cir.nii.ac.jp
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients
with advanced metastatic malignant melanoma | CiNii Research CiNii 国立情報学研究所 学術 …
with advanced metastatic malignant melanoma | CiNii Research CiNii 国立情報学研究所 学術 …